{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:28:10Z","timestamp":1790299690033,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neuro.2021.06.008","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:26:36Z","timestamp":1625225196000},"page":"26-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Developmental Perfluorooctanesulfonic acid (PFOS) exposure as a potential risk factor for late-onset Alzheimer\u2019s disease in CD-1 mice and SH-SY5Y cells"],"prefix":"10.1016","volume":"86","author":[{"given":"Veronia","family":"Basaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1303-3632","authenticated-orcid":false,"given":"Jaunetta","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0394-7887","authenticated-orcid":false,"given":"Syed Waseem","family":"Bihaqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-8154","authenticated-orcid":false,"given":"Emily","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-7001","authenticated-orcid":false,"given":"Angela L.","family":"Slitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser H.","family":"Zawia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2021.06.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuro.2014.06.008","article-title":"Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: relevance to AD","author":"Bihaqi","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2021.06.008_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuro.2017.07.029","article-title":"Lead exposure and tau hyperphosphorylation: an in-vitro study","volume":"62","author":"Bihaqi","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2021.06.008_bib0015","doi-asserted-by":"crossref","DOI":"10.2174\/1567205015666180801095925","article-title":"Influence of early life lead (Pb) exposure on \u03b1-synuclein, GSK-3\u03b2 and caspase-3 mediated tauopathy: implications on Alzheimer\u2019s disease","author":"Bihaqi","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuro.2021.06.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","author":"Brecht","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2009.01.004","article-title":"Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in Sprague Dawley rats","author":"Butenhoff","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0030","article-title":"Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys","author":"Chang","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuro.2018.03.003","article-title":"Per fl uorooctanesulfonate induces neuroinflammation through the secretion of TNF-alpha mediated by the JAK2\/STAT3 pathway","volume":"66","author":"Chen","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2021.06.008_bib0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","author":"Deture","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuro.2021.06.008_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00343","article-title":"Neurodegeneration and microtubule dynamics: death by a thousand cuts","author":"Dubey","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105324","article-title":"Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma","author":"Forsthuber","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.neuro.2021.06.008_bib0055","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfm121","article-title":"Concurrent exposure to perfluorooctane sulfonate and restraint stress during pregnancy in mice: effects on postnatal development and behavior of the offspring","author":"Fuentes","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2007.09.012","article-title":"Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS)","author":"Fuentes","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2021.06.008_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/S0955-0674(00)00172-1","article-title":"Going new places using an old MAP: tau, microtubules and human neurodegenerative disease","author":"Garcia","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0070","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein e, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide","author":"Hashimoto","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0075","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.252","article-title":"Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration","author":"H\u00f6glund","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuro.2021.06.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2021.06.008_bib0085","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","article-title":"Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3beta in brain","volume":"93","author":"Hoshi","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuro.2021.06.008_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2010.04.004","article-title":"A\u03b2-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer\u2019s disease","author":"Huang","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuro.2021.06.008_bib0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuro.2021.06.008_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and a\u03b2 secretion","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuro.2021.06.008_bib0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuro.2007.10.008","article-title":"Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice","volume":"29","author":"Johansson","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2021.06.008_bib0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kfp029","article-title":"Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain","volume":"108","author":"Johansson","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aws127","article-title":"Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-\u03b2","author":"Koffie","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2021.06.008_bib0120","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfg122","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation","author":"Lau","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.taap.2003.11.031","article-title":"The developmental toxicity of perfluoroalkyl acids and their derivatives","volume":"198","author":"Lau","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0130","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfj105","article-title":"Effects of perfluorooctanoic acid exposure during pregnancy in the mouse","author":"Lau","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0140","article-title":"Apolipoprotein e and Alzheimer disease: risk, mechanisms and therapy","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002502","article-title":"Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: a prospective study","volume":"15","author":"Liu","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuro.2021.06.008_bib0150","article-title":"Neurotoxicity of perfluorooctane sulfonate to hippocampal cells in adult mice","author":"Long","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2021.06.008_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2005.07.018","article-title":"Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats","author":"Luebker","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2021.06.008_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1289\/ehp.1003096","article-title":"Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in british girls","volume":"120","author":"Maisonet","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuro.2021.06.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8590578","article-title":"The role of reactive oxygen species in the pathogenesis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: a mini review","author":"Manoharan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuro.2021.06.008_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer\u2019s disease","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuro.2021.06.008_bib0175","doi-asserted-by":"crossref","DOI":"10.1289\/ehp.1104538","article-title":"Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water","author":"Mondal","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuro.2021.06.008_bib0180","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-\u03b2 peptide","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuro.2021.06.008_bib0185","doi-asserted-by":"crossref","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuro.2021.06.008_bib0190","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","author":"Pfrieger","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/S0166-2236(02)00038-3","article-title":"Traffic at the intersection of neurotrophic factor signaling and neurodegeneration","author":"Salehi","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuro.2021.06.008_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2019.106821","article-title":"ROS-mediated JNK pathway critically contributes to PFOS-triggered apoptosis in SH-SY5Y cells","author":"Sun","year":"2019","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0205","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","article-title":"Levels of soluble apolipoprotein E\/amyloid-beta (Abeta) complex are reduced and oligomeric Abeta increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples","volume":"288","author":"Tai","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuro.2021.06.008_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0215","article-title":"Perinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring","volume":"9","author":"Wan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2021.06.008_bib0220","article-title":"Effects of developmental perfluorooctane sulfonate exposure on spatial learning and memory ability of rats and mechanism associated with synaptic plasticity","author":"Wang","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuro.2021.06.008_bib0225","article-title":"Neurotoxic effects of perfluoroalkyl acids: neurobehavioral deficit and its molecular mechanism","author":"Wang","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuro.2021.06.008_bib0230","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.envpol.2016.12.010","article-title":"Perfluoroalkyl acids and their precursors in indoor air sampled in children\u2019s bedrooms","volume":"222","author":"Winkens","year":"2017","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.neuro.2021.06.008_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)38094-9","article-title":"Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes","author":"Zannis","year":"1982","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuro.2021.06.008_bib0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuro.2010.10.001","article-title":"Inflammation-like glial response in rat brain induced by prenatal PFOS exposure","volume":"32","author":"Zeng","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2021.06.008_bib0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tox.2016.03.003","article-title":"Developmental perfluorooctane sulfonate exposure results in tau hyperphosphorylation and \u03b2-amyloid aggregation in adults rats: incidence for link to Alzheimer\u2019s disease","volume":"347\u2013349","author":"Zhang","year":"2016","journal-title":"Toxicology"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X2100070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X2100070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:22:29Z","timestamp":1758982949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X2100070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":49,"alternative-id":["S0161813X2100070X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2021.06.008","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developmental Perfluorooctanesulfonic acid (PFOS) exposure as a potential risk factor for late-onset Alzheimer\u2019s disease in CD-1 mice and SH-SY5Y cells","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2021.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}